*Some Market data delayed by 15 mins.

EyePoint Pharmaceuticals, Inc. Common Stock

Symbol: EYPT (NASDAQ)
13.94 ▲ (17.34%) 2.060

Company Description:
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Key Stats
  • Today's Open: $11.95
  • Today's High: $14.365
  • Today's Low: $11.85
  • Today's Volume: 1.92M
  • Yesterday Close: $11.88
  • Yesterday High: $12.07
  • Yesterday Low: $11.38
  • Yesterday Volume: 781.89K
  • Last Min Volume: 1
  • Last Min High: $13.94
  • Last Min Low: $13.94
  • Last Min VWAP: $13.94
Company Profile
  • Name: EyePoint Pharmaceuticals, Inc. Common Stock
  • Website: https://www.eyepointpharma.com
  • Listed Date: 2005-01-27
  • Location: WATERTOWN, MA
  • Market Status: Active
  • CIK Number: 0001314102
  • SIC Code: 3826
  • SIC description: LABORATORY ANALYTICAL INSTRUMENTS
  • Market Cap: $965.67M
  • Round Lot: 100
  • Outstanding Shares: 68.93M
  • Asset Type: CS
RECENT FILINGS FOR EYPT
Filing Date Filing Type Format
2025-08-12 SCHEDULE 13G/A View
2025-08-07 S-8 View
2025-08-07 10-Q View
2025-08-06 8-K View
2025-07-29 8-K/A View
2025-07-29 8-K View
2025-07-11 4 View
2025-07-11 4 View
2025-07-11 4 View
2025-07-08 SCHEDULE 13G/A View
2025-07-02 4 View
2025-06-25 4 View
2025-06-20 8-K View
2025-05-27 4 View
2025-05-27 8-K View
2025-05-19 4 View
2025-05-15 4 View
2025-05-09 DEFA14A View
2025-05-08 10-Q View
2025-05-07 8-K View
Latest News on EYPT

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.